ALKEM – Alcame Signs Agreement with Famous Pacific Cabbage Plates

Las Vegas, August 18, 2021 (PRNewswire) – Alkame Holdings, Inc.

Working with Famous FSF Hosts to Develop and Manufacture the Pacific Signaters Major Signature Plates from West Coast Copkerker Inc. All the dishes were created by famous chefs from restaurant professionals to professional markets to promote their professionalism and bring about natural growth.

“We are very happy to be working with kitchens in the Pacific Youth Bowls,” said Alcame General Manager. Robert Eckle. In the past, we look forward to working with the best to bring these incredible products to consumers.

About West Coast Co Packer, Inc.

West Coast Co Packer, Inc. , Alkame Holdings, Inc. Fully owned and manufactured by Special Liquid and Single Service, Co-Package, Personal Identification and Contract Manufacturer, it is expected to be complementary and seamless integration immediately. Bell Food & Beverage, along with other branches of Alkame, Bell Food & Beverage, Inc. A unique natural, organic liquid-based hot and cold filling food and beverage manufacturer in glass and pet bottles and jars. To learn more about the West Coast Copacker tour

About Alkame Holdings, Inc.

Alcame Holdings is an publicly traded health and safety technology company focused on inpatient, innovative and environmentally friendly consumer products. The company’s full-fledged branches produce patented water using patented technology to create a number of unique properties. The company has launched and acquired appropriate business assets, and followed a number of applications into a number of emerging business sectors such as consumer bottled water and RTD products, pet products, horticultural and agricultural applications, hand sanitizers for new and existing business platforms and much more. Water-based treatment solutions.

Visit for more information

Alkame Holdings, Investor Relations
Phone: 702-273-9714

Disclaimer / Safe Harbor: This newsletter contains forward-looking statements in the translation of the Safe Arbitration Amendment Act. The statements reflect the company’s current views on future events, including risks and mistrust. Among other risks, these risks include significant sales, failure to meet the company’s contract timetable or performance requirements, the company’s liquidity, the company’s ability to obtain new contracts, the emergence of highly competitive competitors, and the impact of competitive prices. In light of these instability, future events mentioned in this release may not occur. These statements have not been reviewed by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.


See original content: https: //—alkame-signs-production-agreement-with

Source: Alkame Holdings, Inc.

Leave a Comment